ARBS: Strong profit growth and R&D advances support a positive outlook and dividend proposal

About this update from Arterra Bioscience Spa

Production value and net profit grew strongly year-over-year, driven by a surge in cosmetic raw material sales and robust R&D activity. Financial position remains solid, with optimism for continued growth in 2025 and a proposed dividend of €0.13 per share.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Arterra Bioscience Spa